WOOJUNG BIO Inc (215380) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.22x

WOOJUNG BIO Inc (215380) has a Cash Flow Reinvestment Rate of 0.22x as of March 2025, reinvesting ₩349.76 Million (capex ₩191.51 Million plus investments ₩158.25 Million) from operating cash flow of ₩1.59 Billion. Check 215380 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.22x
(Capex + Investments) / Operating CF

Total Reinvested

₩349.76 Million
Capex + Investments

Operating Cash Flow

₩1.59 Billion
KRW

Capital Expenditures

₩191.51 Million
KRW

WOOJUNG BIO Inc Cash Flow Reinvestment Rate (2019–2022)

Historical reinvestment intensity for WOOJUNG BIO Inc across 3 annual periods. Explore 215380 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for WOOJUNG BIO Inc (2019–2022)

Year-by-year capital reinvestment analysis for WOOJUNG BIO Inc. For live market cap and broader valuation context, see market value of WOOJUNG BIO Inc.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2022 6.49x ₩16.25 Billion ₩2.50 Billion ₩11.42 Billion ▼ -74.2%
2021 25.22x ₩43.58 Billion ₩1.73 Billion ₩36.68 Billion ▼ -30.3%
2019 36.16x ₩7.55 Billion ₩208.72 Million ₩2.16 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow